Mitsubishi UFJ Asset Management
KYTX icon

Mitsubishi UFJ Asset Management’s Kyverna Therapeutics KYTX Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Buy
+25,741
New +$229K ﹤0.01% 1011

Other funds holding KYTX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mitsubishi UFJ Asset Management's KYTX Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management opened a new position in Kyverna Therapeutics (KYTX) in Q2 2026: 25,741 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #1011 among its holdings.

39 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 25,741 shares of Kyverna Therapeutics worth $229K as of Q2 2026.
  • Kyverna Therapeutics was a new Mitsubishi UFJ Asset Management position in Q2 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1011 holding.
  • 39 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.